Shopping Cart

Imagion Bio at The Edison Open House: Global Healthcare 2022

Imagion Bio at The Edison Open House: Global Healthcare 2022

Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging MagSense technology and where we hope to make a big difference in early cancer detection.

Watch the full interview here:

Visit our technology pages to learn more about our PrecisionMRX Nanoparticles or our MagSense Technology.

CONTACT US with any questions.

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.